| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.28 | 3e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-12 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.31 | 4e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.27 | 5e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |